<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02034240</url>
  </required_header>
  <id_info>
    <org_study_id>DNVK:1305 385</org_study_id>
    <nct_id>NCT02034240</nct_id>
  </id_info>
  <brief_title>Neutrophil Gelatinase Associated Lipocalin (NGAL) in Urine: Can This Prove to be a Biomarker for Acute Kidney Injury in Patients With Sepsis?</brief_title>
  <official_title>Secretion of Neutrophil Gelatinase Associated Lipocalin in Septic Patients and the Development of Acute Kidney Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sygehus Lillebaelt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kolding Sygehus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sygehus Lillebaelt</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with severe infection and sepsis are in high risk of hypo perfusion and therefore
      organ affection. Temporary or permanent kidney failure is a common complication in these
      patients. Today's golden standard for kidney failure detection is creatinine levels rising
      and / or oliguria. The investigators hypothesize that an even more sensitive biomarker;
      neutrophil gelatinase associated lipocalin(NGAL) in urine can predict kidney injury before
      creatinine levels rise. In recent studies NGAL in urine seem to be a sensitive biomarker in
      these patient to predict kidney injury, but the time factor for sampling optimally is not
      known. In this pilot study the investigators sample the urine at admission within the first
      hour of hospitalization to investigate if NGAL can be used as a predictor in an emergency
      setting.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <target_duration>5 Weeks</target_duration>
  <primary_outcome>
    <measure>Development of Acute Kidney Failure</measure>
    <time_frame>During hospitalization, anticipated approximately 5 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Levels of NGAL in patients with kidney failure compared to creatinine</measure>
    <time_frame>During hospitalization, anticipated approximately 5 weeks</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">21</enrollment>
  <condition>Severe Sepsis</condition>
  <condition>Septic Shock</condition>
  <condition>Acute Kidney Injury</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with no prior record of kidney failure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe sepsis

          -  Septic shock

          -  Patients must not be able to give consent

        Exclusion Criteria:

          -  Underaged (18 years )

          -  known kidney injury

          -  Fully alert patients that can give consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jannie Bisgaard St√¶hr, PhD, M.D</last_name>
    <role>Study Chair</role>
    <affiliation>Odense University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claes Falkenberg Elvander, M.D</last_name>
    <role>Study Director</role>
    <affiliation>Kolding Sygehus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Srishamanthi Sriskandarajah, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kolding Sygehus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faelles Akut Modtagelse, Kolding Sygehus</name>
      <address>
        <city>Kolding</city>
        <zip>6000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2014</study_first_submitted>
  <study_first_submitted_qc>January 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2014</study_first_posted>
  <last_update_submitted>April 19, 2015</last_update_submitted>
  <last_update_submitted_qc>April 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sygehus Lillebaelt</investigator_affiliation>
    <investigator_full_name>Claes Falkenberg Elvander</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

